AVTX
#2622
Avalo Therapeutics, Inc. - Common Stock
13.2 4 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.00%
Variación mensual
-19.42%
Variación en los últimos 6 meses
-2.36%
Cambio anual
-2.58%
Cierres anteriores
13.6 5
Open
13.5 6
Mínimo
13.1 3
Máximo
13.6 9
Financials
2018
Current report, 26 Dec 2018
Avalo Therapeutics, Inc. current report, 26 December 2018
8-K
Current report, 27 Nov 2018
Avalo Therapeutics, Inc. current report, 27 November 2018
8-K
Current report, 13 Nov 2018
Avalo Therapeutics, Inc. current report, 13 November 2018
8-K
Quarterly report, Q3 FY2018
Avalo Therapeutics, Inc. quarterly report, Q3 FY2018
10-Q
Current report, 27 Sep 2018
Avalo Therapeutics, Inc. current report, 27 September 2018
8-K
Current report, 24 Sep 2018
Avalo Therapeutics, Inc. current report, 24 September 2018
8-K
Current report, 14 Sep 2018
Avalo Therapeutics, Inc. current report, 14 September 2018
8-K
Current report, 05 Sep 2018
Avalo Therapeutics, Inc. current report, 05 September 2018
8-K
Current report, 17 Aug 2018
Avalo Therapeutics, Inc. current report, 17 August 2018
8-K
Current report, 09 Aug 2018
Avalo Therapeutics, Inc. current report, 09 August 2018
8-K